CD163 is a predictive biomarker for prognosis of classical Hodgkin's lymphoma in Saudi patients

Hodgkin's lymphoma (HL) is a hematological malignancy characterized by a minority of neoplastic cells outnumbered by tumor-associated macrophages (TAMs). The overexpression of the CD163 antigen by TAMs is considered to be a significant predictive biomarker for risk stratification. This is likel...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Huda Al Sayed, Raslan, Wasim Fawzi, Deifalla, Abdel Halim Salem, Fathallah, Mohammad Dahmani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535641/
https://www.ncbi.nlm.nih.gov/pubmed/31289681
http://dx.doi.org/10.3892/mco.2019.1850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535641/
https://www.ncbi.nlm.nih.gov/pubmed/31289681
http://dx.doi.org/10.3892/mco.2019.1850

Ejemplares similares